Professor Dean Fennell, “Oncology: Advancements and Challenges in Treating Mesothelioma“ ADAO 13:27 9 years ago 645 Скачать Далее
Assessing the link between the gut microbiome and response rates in mesothelioma VJOncology 1:06 2 months ago 19 Скачать Далее
Overview of therapeutic targets of interest in the treatment of mesothelioma VJOncology 1:50 1 month ago 23 Скачать Далее
ATOMIC: treating mesothelioma with an arginine-degrading enzyme and combination chemotherapy VJOncology 1:14 1 year ago 122 Скачать Далее
MITOPE: RSO-021, a novel PRX3 inhibitor, in mesothelioma or other pleural cancers VJOncology 3:54 2 months ago 29 Скачать Далее
MiST5: niraparib and dostarlimab in relapsed malignant mesothelioma VJOncology 3:34 2 months ago 38 Скачать Далее
Abemaciclib in patients with p16ink4a negative, relapsed mesothelioma VJOncology 1:54 3 years ago 155 Скачать Далее
MiST: personalized approaches to mesothelioma treatment VJOncology 8:21 3 years ago 1 392 Скачать Далее
Discussion of the results from the BEAT-meso trial in pleural mesothelioma VJOncology 2:36 1 month ago 61 Скачать Далее
Cutting-edge UK trials for mesothelioma: double immuno, arginine depletion and molecular profiling VJOncology 1:35 6 years ago 522 Скачать Далее
Therapeutic targets for mesothelioma and sarcomatoid carcinoma VJOncology 3:05 5 years ago 559 Скачать Далее